Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukaemia or undergoing allogeneic bone marrow transplant.
about
Comparison of echinocandin antifungalsCombined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysisCombination treatment of invasive fungal infections.Caspofungin: an overview.A review of clinical experience with newer antifungals in childrenSuccessful treatment of liver aspergilloma by caspofungin acetate first-line therapy in a non-immunocompromised patient.Echinocandin antifungals: review and update.Fungal pneumonia due to molds in patients with hematological malignancies.Experiences with the use of caspofungin in paediatric patients.A clinical review of echinocandins in pediatric patients.Caspofungin therapy in immunocompromised children and neonates.A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections.Compassionate use study of caspofungin in children with proven or suspected invasive mycosis or persistent febrile neutropenia.Successful treatment of disseminated aspergillosis with the combination of voriconazole, caspofungin, granulocyte transfusions, and surgery followed by allogeneic blood stem cell transplantation in a patient with primary failure of an autologous steCaspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies.Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (Combistrat trial).Caspofungin treatment in two infants with persistent fungaemia due to Candida lipolytica.
P2860
Q28273738-1549AAB1-11F1-4475-BA3F-BD8E9B009655Q33857685-D44345BB-2B7D-4FDF-ACFD-B07718418FABQ34322081-EFB20A89-648A-4599-B4C2-BEBAB2EF72DFQ36011378-C43D2EE6-D51B-48C4-96FE-6EA5BA7FCF9FQ36278031-2A922DD5-0C60-4187-B972-D5BA352140F8Q36290698-6FD7AE8F-37F2-4549-9DB8-1FB6F4195702Q36321765-A85F2EC2-10F7-47B4-9137-77339E94115AQ36441524-3F10E96C-FFD9-45C1-A6D0-9585C737AABCQ36616182-CD75A681-32A2-48DB-89DF-D6A001CD16F3Q37159589-9616D584-8747-4936-842A-3203863BCECFQ37653647-B68E1A99-CEF7-42D8-A3BA-8260804BC192Q37854725-7B9031B3-AD50-458B-88EC-71802A8C41A6Q43742898-D56649AB-DBC7-4440-9D1D-FAD93A34D0C4Q46021270-ACE66787-A497-4C27-8258-856B00787F18Q46425067-E50F4CD2-4C23-48F8-9C68-D2F21A4D21D6Q46653990-D4125B9F-09FC-457D-9C88-0A7A520B8158Q46946844-1227E284-3524-4534-99C4-40346C27E8C7Q51173691-794EE002-A498-41B7-BD0F-9A75D31DCAE4
P2860
Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukaemia or undergoing allogeneic bone marrow transplant.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Caspofungin associated with li ...... geneic bone marrow transplant.
@en
Caspofungin associated with li ...... geneic bone marrow transplant.
@nl
type
label
Caspofungin associated with li ...... geneic bone marrow transplant.
@en
Caspofungin associated with li ...... geneic bone marrow transplant.
@nl
prefLabel
Caspofungin associated with li ...... geneic bone marrow transplant.
@en
Caspofungin associated with li ...... geneic bone marrow transplant.
@nl
P2093
P1476
Caspofungin associated with li ...... ogeneic bone marrow transplant
@en
P2093
B Cappelli
E Castagnola
G Morreale
M Machetti
P304
P356
10.1111/J.1198-743X.2004.00837.X
P577
2004-03-01T00:00:00Z